Negotiating the maze of biotech "tool patents".
Circumventing existing patents may be a shortcut to getting your recombinant protein to market.
Mascarenhas
D
D
Celtrix Pharmaceuticals, Santa Clara, CA 95054-1815, USA. desmond@celtrix.com
D001709:Biotechnology; D017008:Negotiating; D010330:Patents as Topic; D011994:Recombinant Proteins
D011994:Recombinant Proteins